187 related articles for article (PubMed ID: 21427537)
1. Chronic β blockade is associated with a better outcome after elective noncardiac surgery than acute β blockade: a single-center propensity-matched cohort study.
Ellenberger C; Tait G; Beattie WS
Anesthesiology; 2011 Apr; 114(4):817-23. PubMed ID: 21427537
[TBL] [Abstract][Full Text] [Related]
2. beta-Blockade in noncardiac surgery: outcome at all levels of cardiac risk.
Kaafarani HM; Atluri PV; Thornby J; Itani KM
Arch Surg; 2008 Oct; 143(10):940-4; discussion 944. PubMed ID: 18936371
[TBL] [Abstract][Full Text] [Related]
3. Perioperative beta-blocker therapy and heart rate control during noncardiac surgery.
Berg C; Berger DH; Makia A; Whalen C; Albo D; Bellows C; Awad SS
Am J Surg; 2007 Aug; 194(2):189-91. PubMed ID: 17618802
[TBL] [Abstract][Full Text] [Related]
4. The effect of beta-blocker dosing strategy on regulation of perioperative heart rate and clinical outcomes in patients undergoing vascular surgery: a randomized comparison.
Cesanek P; Schwann N; Wilson E; Urffer S; Maksimik C; Nabhan S; Ottinger J; Astbury J; Xiang Y; Matsumura ME
Ann Vasc Surg; 2008 Sep; 22(5):643-8. PubMed ID: 18562162
[TBL] [Abstract][Full Text] [Related]
5. Perioperative beta-blocker therapy and mortality after major noncardiac surgery.
Lindenauer PK; Pekow P; Wang K; Mamidi DK; Gutierrez B; Benjamin EM
N Engl J Med; 2005 Jul; 353(4):349-61. PubMed ID: 16049209
[TBL] [Abstract][Full Text] [Related]
6. Effect of beta-blocker prescription on the incidence of postoperative myocardial infarction after hip and knee arthroplasty.
van Klei WA; Bryson GL; Yang H; Forster AJ
Anesthesiology; 2009 Oct; 111(4):717-24. PubMed ID: 19707119
[TBL] [Abstract][Full Text] [Related]
7. Sex-related differences in outcome after high-risk vascular surgery after the administration of beta-adrenergic-blocking drugs.
Matyal R; Mahmood F; Panzica P; Pomposelli F; Park KW; Hamden A; Schermerhorn M; Hess P
J Cardiothorac Vasc Anesth; 2008 Jun; 22(3):354-60. PubMed ID: 18503921
[TBL] [Abstract][Full Text] [Related]
8. Increase of 1-year mortality after perioperative beta-blocker withdrawal in endovascular and vascular surgery patients.
Hoeks SE; Scholte Op Reimer WJ; van Urk H; Jörning PJ; Boersma E; Simoons ML; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2007 Jan; 33(1):13-9. PubMed ID: 16935011
[TBL] [Abstract][Full Text] [Related]
9. Acute surgical anemia influences the cardioprotective effects of beta-blockade: a single-center, propensity-matched cohort study.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G; Mitsakakis N; Hare GM
Anesthesiology; 2010 Jan; 112(1):25-33. PubMed ID: 20032700
[TBL] [Abstract][Full Text] [Related]
10. Duration of preoperative β-blockade and outcomes after major elective noncardiac surgery.
Wijeysundera DN; Beattie WS; Wijeysundera HC; Yun L; Austin PC; Ko DT
Can J Cardiol; 2014 Feb; 30(2):217-23. PubMed ID: 24373755
[TBL] [Abstract][Full Text] [Related]
11. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial.
Yang H; Raymer K; Butler R; Parlow J; Roberts R
Am Heart J; 2006 Nov; 152(5):983-90. PubMed ID: 17070177
[TBL] [Abstract][Full Text] [Related]
12. Perioperative beta-blocker and statin therapy.
Daumerie G; Fleisher LA
Curr Opin Anaesthesiol; 2008 Feb; 21(1):60-5. PubMed ID: 18195612
[TBL] [Abstract][Full Text] [Related]
13. The Diabetic Postoperative Mortality and Morbidity (DIPOM) trial: rationale and design of a multicenter, randomized, placebo-controlled, clinical trial of metoprolol for patients with diabetes mellitus who are undergoing major noncardiac surgery.
Juul AB; Wetterslev J; Kofoed-Enevoldsen A; Callesen T; Jensen G; Gluud C;
Am Heart J; 2004 Apr; 147(4):677-83. PubMed ID: 15077084
[TBL] [Abstract][Full Text] [Related]
14. Acute peri-operative beta blockade in intermediate-risk patients.
Biccard BM; Sear JW; Foëx P
Anaesthesia; 2006 Oct; 61(10):924-31. PubMed ID: 16978304
[TBL] [Abstract][Full Text] [Related]
15. ß-Blockers reduce mortality in patients undergoing high-risk non-cardiac surgery.
Angeli F; Verdecchia P; Karthikeyan G; Mazzotta G; Gentile G; Reboldi G
Am J Cardiovasc Drugs; 2010; 10(4):247-59. PubMed ID: 20653331
[TBL] [Abstract][Full Text] [Related]
16. [Organprotection in cardiac risk patients--rational of perioperative beta-adrenoceptor-antagonists and statins].
Hanss R; Bein B
Anasthesiol Intensivmed Notfallmed Schmerzther; 2010 Apr; 45(4):246-52; quiz 253. PubMed ID: 20387182
[TBL] [Abstract][Full Text] [Related]
17. Perioperative beta blockade in noncardiac surgery: a review of the literature.
Mason KE; Davis LL
AANA J; 2006 Apr; 74(2):113-7. PubMed ID: 16617914
[TBL] [Abstract][Full Text] [Related]
18. Perioperative beta-blockers for major noncardiac surgery: Primum Non Nocere.
Chopra V; Plaisance B; Cavusoglu E; Flanders SA; Eagle KA
Am J Med; 2009 Mar; 122(3):222-9. PubMed ID: 19185285
[TBL] [Abstract][Full Text] [Related]
19. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade.
Lindenauer PK; Fitzgerald J; Hoople N; Benjamin EM
Arch Intern Med; 2004 Apr; 164(7):762-6. PubMed ID: 15078646
[TBL] [Abstract][Full Text] [Related]
20. [Perioperative betablockade].
Skarvan K
Cas Lek Cesk; 2007; 146(4):321-8. PubMed ID: 17491241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
